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Abstract
Background: Hyperactivity of the epithelial sodium (Na
+) channel (ENaC) and increased Na
+ absorption by airway
epithelial cells leading to airway surface liquid dehydration and impaired mucociliary clearance are thought to play
an important role in the pathogenesis of cystic fibrosis (CF) pulmonary disease. In airway epithelial cells, ENaC is
constitutively activated by endogenous trypsin-like serine proteases such as Channel-Activating Proteases (CAPs). It
was recently reported that ENaC activity could also be stimulated by apical treatment with human neutrophil
elastase (hNE) in a human airway epithelial cell line, suggesting that hNE inhibition could represent a novel
therapeutic approach for CF lung disease. However, whether hNE can also activate Na
+ reabsorption in primary
human nasal epithelial cells (HNEC) from control or CF patients is currently unknown.
Methods: We evaluated by short-circuit current (Isc) measurements the effects of hNE and EPI-hNE4, a specific hNE
inhibitor, on ENaC activity in primary cultures of HNEC obtained from control (9) and CF (4) patients.
Results: Neither hNE nor EPI-hNE4 treatments did modify Isc in control and CF HNEC. Incubation with aprotinin, a
Kunitz-type serine protease inhibitor that blocks the activity of endogenous CAPs, decreased Isc by 27.6% and 54%
in control and CF HNEC, respectively. In control and CF HNEC pretreated with aprotinin, hNE did significantly
stimulate Isc, an effect which was blocked by EPI-hNE4.
Conclusions: These results indicate that hNE does activate ENaC and transepithelial Na
+ transport in both normal
and CF HNEC, on condition that the activity of endogenous CAPs is first inhibited. The potent inhibitory effect of
EPI-hNE4 on hNE-mediated ENaC activation observed in our experiments highlights that the use of EPI-hNE4 could
be of interest to reduce ENaC hyperactivity in CF airways.
Introduction
Abnormalities in cyclic AMP-dependent chloride secre-
tion and excessive sodium (Na
+) reuptake by airway
epithelial cells related to cystic fibrosis transmembrane
conductance regulator (CFTR) deficiency are thought to
alter fluid homeostasis at the airway surface liquid lead-
ing to dehydration, impaired mucociliary clearance, and
infection [1]. Activation of CFTR Cl
- channel is known
to inhibit epithelial Na
+ channel (ENaC) in normal
native airway epithelial cells. In CF airways, mutation of
CFTR leads to increased ENaC activity with increased
transepithelial Na
+ and water reabsorption [2-5]. Indeed,
it has been shown that overexpression of the b-ENaC
subunit in mouse airways increases Na
+ reabsorption,
decreases mucociliary and bacterial clearance and leads
to airway inflammation and obstruction, and to a cystic
fibrosis-like disease [6]. Therefore, inhibition of ENaC
activity in the airways has been proposed for treatment
of CF pulmonary disease.
Despite its physiological importance in lung fluid home-
ostasis, the tissue-specific regulation of ENaC in airways is
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systemic regulation of ENaC by hormones [7], but the role
of extracellular luminal factors present in the immediate
vicinity of the channel has been scarcely investigated. In
recent years, the concept of an autocrine regulation of
ENaC by epithelium derived extracellular serine proteases
has emerged from several observations [8,9]. In 1997,
using functional complementation assays to detect
increases in ENaC activity in the Xenopus kidney A6 renal
cell line, Vallet et al (10) cloned a trypsin-like serine pro-
tease, the channel-activating protease 1 (CAP1). This
glycosylphophatidylinositol-anchored protease increased
amiloride-sensitive Na
+ current when coexpessed ENaC in
Xenopus oocytes [10,11]. ENaC activation was fully pre-
vented by extracellular addition of the serine protease
inhibitor aprotinin and mimicked by external tryspsin.
Mammalian homologs of Xenopus CAP1, such as mouse
mCAP1 or human and rat prostasin, were also shown to
activate ENaC in the Xenopus oocytes expression system
[12-15]. More recently, additional transmembrane serine
proteases activating ENaC have been identified in mam-
mals, including channel-activating protease 2 (CAP2) and
channel-activating protease 3 (CAP3) cloned from the
mpkCCDd4 mouse kidney cell line [14], TMPRSS3 from
human inner ear [16], or TMSP-1 from rat kidney [17].
The precise mechanism for protease-mediated activation
of ENaC has not been fully elucidated, but it likely involves
proteolytic cleavage of a-a n dg-ENaC subunits [9,16].
Studies in Xenopus oocytes [13,14,17] or transfected mam-
malian cells [18] have demonstrated that trypsin-like ser-
ine proteases increase Na
+ transport by activating a
population of near-silent channels rather than by promot-
ing plasma membrane insertion of new channels. In mam-
mals, the channel-activating proteases (CAP1,-2 and 3) are
coexpressed with ENaC in epithelial tissues transporting
Na
+ like renal collecting duct, lung, and colon [12,19,20].
Concerning the lung, we have recently shown that CAP1
is an important regulator of transepithelial alveolar Na
+
transport in vitro and in vivo, and of lung fluid homeosta-
sis in the mouse [21,22]. Indeed, it was reported that Na
+
absorption across bronchial or nasal epithelial cells was
regulated in vitro by endogenous aprotinin-sensitive serine
protease(s) [15,23]. Prostasin, the human homolog of
CAP1 expressed in proximal airways, was proposed as a
likely candidate for this regulation [15,24].
Caldwell et al recently reported that ENaC activity
and transepithelial Na
+ transport could be increased by
apical treatment with human neutrophil elastase (hNE)
in a human airway epithelial cell line [18]. However, it
seems that this human airway epithelial cell line did not
have any endogenous CAP activity inasmuch as treat-
ment with aprotinin, an inhibitor of endogenous CAPs,
did not modify transepithelial Na
+ transport. Whether
hNE can also activate ENaC and Na
+ reabsorption in
primary bronchial cells known to endogenously express
CAPs is currently unknown. This is an important point
inasmuch as hNE can be found at high concentration in
airway surface liquid from CF patients, due to neutro-
phil activation. If hNE does activate ENaC and transe-
pithelial Na
+ transport in CF airways, the use of hNE
inhibitors could have a therapeutic interest for treat-
ment of CF lung disease.
Our working hypotheses were (i) that hNE would
stimulate ENaC and transepithelial Na
+ transport in
primary human airway epithelial cells, and (ii) that EPI-
hNE4, a specific and potent inhibitor of hNE [22], could
block this stimulation. The objectives of the study were
therefore to test the effects of hNE and EPI-hNE4 on
ENaC activity and transepithelial Na
+ transport in vitro
in primary cultures of human nasal epithelial cells from
control and CF patients.
Experimental Procedures
Primary cultures of human nasal epithelial cells (HNEC)
Nasal polyps (NP) were obtained from non CF (n = 9)
or CF (ΔF508/ΔF508, n = 4) patients requiring surgery
for their nasal polyposis as previously described [25].
The diagnosis of nasal polyposis was established on the
basis of clinical history, endoscopic findings and com-
puted tomography results. This protocol was approved
by the Institutional Review Board and ethics committee
of our institution (CPP, Hôpital Henri Mondor), and
informed consent was obtained from all patients. NP
samples were immediately placed in DMEM/F12 supple-
mented with antibiotics (100 U/ml of penicillin, 100
mg/ml of streptomycin, 2.5 μg/ml of amphotericin B
and 100 mg/ml of gentamicin) and transported to the
laboratory for cell isolation. Briefly, NP samples were
rinsed in phosphate-buffered saline (PBS) with dithio-
threitol (5 nM) and antibiotics (100 U/ml of penicillin,
100 mg/ml of streptomycin, 2.5 μg/mL of amphotericin
B and 100 mg/ml of gentamicin) and then placed over-
night at 4°C in a PBS-antibiotics solution containing
0.1% pronase. The samples were incubated in DMEM/
F12 with 5% fetal calf serum (FCS) before centrifugation
(1,500 rpm, 7 minutes). Cell pellets were then sus-
pended in 0.25% trypsin-ethylenediamine tetra-acetic
acid (EDTA) solution for 3 minutes and incubated in
DMEM/F12-antibiotics with 10% FCS. Finally, HNEC
were plated on permeable polycarbonate supports
(Snapwell®, Costar, Cambridge, USA) (1 × 10
6cells/cm
2)
for short-circuit measurements. All inserts had a dia-
meter of 12-mm and were coated with type IV collagen.
HNEC were incubated at 37°C in 5% CO2. For the first
24 hours, HNEC were incubated with 1 ml of DMEM/
F12-antibiotics with 2% Ultroser G outside the insert
and DMEM/F12-antibiotics with 10% FCS inside the
insert. After 24 hours, medium was removed inside the
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face, and medium outside the inserts was then changed
daily. Transepithelial resistance and transepithelial
potential difference were measured every three days
using a microvoltmeter (World Precision Instruments,
Astonbury, UK). Experiments were performed 2-3 weeks
after isolation.
Electrophysiological studies
Measurements of short-circuit current (Isc), transepithe-
lial potential difference, and transepithelial resistance
were performed in Snapwell inserts mounted in vertical
diffusion chambers and bathed with Ringer solution (pH
7.4) continuously bubbled with 5% CO2-95% air at 37°C.
The apical and basolateral chambers were filled with (in
mM): 137 NaCl, 5.6 KCl, 1.9 CaCl2,1 . 2M g C l 2,5 . 9
CH3COONa, 1.3 NaH2PO4, 10 HEPES and 10 glucose.
PD was short-circuited to 0 mV with a voltage clamp
(World Precision Instruments, Astonbury, UK) con-
nected to the apical and basolateral chambers via Ag-
AgCl electrodes and agar bridges in order to measure Isc
by Ohm’s law. Isc was allowed to stabilize, before adding
the drugs.
Treatment of HNEC cultures
Human neutrophil elastase (Serva Electrophoresis; final
concentration: 10 or 33 μg/ml, equivalent to 0.2 and
0.66 U/ml, respectively), EPI-hNE4 (developed by Dyax
Corp., Cambridge, MA; final concentration: 10 or 33 μg/
ml), trypsin (Sigma; final concentration: 100 μg/ml,
equivalent to 1,000 BAEE units/ml) or vehicle were
added after establishing a stable Isc into the apical com-
partment and Isc was monitored for 30 to 60 min before
apical addition of 10 μM amiloride, a specific inhibitor
of ENaC. Amiloride-sensitive Isc was determined as the
difference in current with and without amiloride (10
μM). In the second part of the study, the serine protease
inhibitor aprotinin (Sigma; final concentration: 50 μg/ml,
equivalent to 0.25 Trypsin Inhibitor Unit (TIU)/ml) was
added into the apical compartment and Isc was moni-
tored for 75 to 90 min before apical addition of hNE
alone (final concentration: 33 μg/ml), or of EPI-hNE4
(final concentration: 33 μg/ml) followed by hNE (final
concentration: 33 μg/ml).
Statistical analysis
Data are expressed as% of baseline value (before addi-
tion of drug) or as changes in Isc (ΔIsc , representing the
difference between the value of Isc at the end of expo-
sure to drug or vehicle and the baseline Isc at the
moment of drug or vehicle addition), and are presented
as means ± SE of 4-10 filters per condition. Statistics
were performed on ΔIsc values. Treatment groups were
compared by one-way variance analyses and, when
allowed by the F value, results were compared by the
modified least significant difference (Statview Software).
P < 0.05 was considered significant.
Results
Treatment of control and CF HNEC with hNE
HNEC cultures were derived from nine non-CF and
four CF (homozygous ΔF508/ΔF508) subjects. Thirty-
five individual normal HNEC and nineteen CF HNEC
filters displayed high transepithelial resistance and stable
Isc values, and could be used in this study. Electrophy-
siological properties of cultured HNEC from non CF
and CF patients are presented in Table 1.
We first tested the effect of hNE on transepithelial Na
+
transport in control and CF HNEC monolayers. As shown
in Figure 1, increasing concentrations of hNE (final con-
centration in the apical bath: 10 and 33 μg/ml) did not
induce any noticeable change in Isc value in control
HNEC. Indeed, ΔIsc (representing the difference between
the value of Isc at the end of exposure to drug or vehicle
and the baseline) was not significantly different in cells
treated with hNE as compared with vehicle (Figure 2A)
(n = 4-6). Treatment with excess trypsin (final concentra-
tion: 100 μg/ml), a serine protease known to activate
ENaC and Na
+ transport in lung epithelial cells, also did
not modify Isc value in control HNEC (Figure 2A). Similar
results were obtained in CF HNEC since neither hNE
(final concentration in the apical bath: 10 and 33 μg/ml)
nor trypsin (final concentration: 100 μg/ml) did signifi-
cantly modify ΔIsc as compared with vehicle (n = 3-4)
(Figure 1 and 2B). These data show that, in cultured
HNEC, ENaC-mediated transepithelial Na
+ transport
could not be stimulated by treatment with exogenous
serine proteases such as hNE and trypsin.
Treatment of control and CF HNEC with EPI-hNE4
We next studied the effect of the hNE inhibitor EPI-
hNE4 on control and CF HNEC to test whether this
compound was able to modify transepithelial Na
+
Table 1 Electrophysiological properties of cultured HNEC
from normal and CF patients
Control HNEC CF HNEC
PD (mV) 36.8 ± 2.18 57 ± 2.23 ***
Rte (Ω.cm
2) 969 ± 67.7 953 ± 48.1
Isc (μA/cm
2) 41.8 ± 3.42 60.7 ± 3.19 **
Human nasal epithelial cells (HNEC) from control (non CF) and CF patients were
grown for 14 to 21 days on semi-permeable transwell filters until transepithelial
resistance developed. Transwell filters were mounted in Ussing chamber for
measurement of voltage (PD) and short-circuit current (Isc). Transepithelial
resistance (Rte) was calculated with Ohm’s law from Isc and PD. Results
represent means ± SE of 25 individual filters from 9 separate cultures of non CF
HNEC, and of 9 individual filters from 4 separate cultures of CF HNEC.
**, ***: significantly different from corresponding value in control HNEC group
(P < 0.01 and P < 0.001, respectively).
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hNE4 (final concentration: 100 μg/ml) did not signifi-
cantly modify Isc in control HNEC (n = 5) or CF HNEC
(n = 4), as compared with vehicle (Table 2).
Effect of hNE and EPI-hNE4 treatment in control and CF
HNEC preincubated with aprotinin
Taken together, the results indicate that neither hNE nor
its inhibitor EPI-hNE4 is able to modify ENaC-mediated
Na
+ transport in HNEC. We hypothesized that this lack
of effect of hNE was due to the expression in HNEC of
endogenous serine proteases known to activate ENaC in
human airway epithelial cells, such as CAPs. To test this
hypothesis, cells were pre-incubated with aprotinin (final
concentration: 50 μg/ml in the apical bath), a Kunitz-type
serine protease inhibitor, before hNE (with or without
EPI-hNE4) was added. Aprotinin induced a 27.6 ± 3.47%
decrease in control HNEC total Isc that was completely
achieved within 90 min (Figure 3, 4 and Table 3). This
decrease was rapidly and completely reversed by apical
addition of hNE (final concentration 33 μg/ml). The
stimulatory effect of hNE on Isc was fully prevented when
cells were treated with EPI-hNE4 (final concentration
33 μg/ml) 5 minutes before hNE addition (ΔIsc:- 1 5 . 7±
3.56 vs -14.2 ± 4.70 μA/cm
2 for aprotinin alone and
aprotinin followed by EPI-hNE4 + hNE, respectively; NS).
In CF HNEC, aprotinin decreased total Isc by 54 ±
8.18% in CF HNEC (Figure 3, 4 and Table 3). The apro-
tinin-induced inhibition of Isc was significantly greater
in CF HNEC than in control HNEC (Table 3). Apical
addition of hNE significantly increased Isc in aprotinin-
treated CF HNEC. HNE-induced stimulation of Isc
tended to be higher in CF HNEC than in control
HNEC, although the difference was not significant (p =
0.06) (Table 3). However, hNE addition did not comple-
tely restore Isc to the baseline value in CF HNEC (Figure
3 and 4). The stimulatory effect of hNE in aprotinin-
treated CF HNEC was completely blocked by preincuba-
tion with EPI-hNE4 (n = 2).
Discussion
This study was designed to test the effect of hNE and its
specific inhibitor EPI-hNE4 on transepithelial Na
+ trans-
port across cultured normal and CF HNEC. Our results
showed that neither hNE nor trypsin treatment did
modify Isc in normal and CF HNEC, suggesting that
ENaC at cell surface was already fully activated by endo-
genous serine proteases such as epithelial CAPs. Indeed,
inhibition of endogenous CAPs with aprotinin induced a
sustained decrease in Isc in both normal and CF HNEC,
supporting this hypothesis. Interestingly, apical treat-
ment with exogenous hNE completely and rapidly
reversed the aprotinin-induced decrease in Isc normal
and CF cells. EPI-hNE4 by itself did not modify Isc in
normal or CF HNEC, indicating that this compound is a
specific inhibitor of hNE and in this way could not inhi-
bit endogenous CAPs. However, EPI-hNE4 completely
abolished the stimulatory effect of hNE in cells pre-
treated with aprotinin in normal and CF patients. Taken
together, our results suggest that in some conditions
when endogenous CAPs are downregulated, hNE could
stimulate ENaC-mediated Na
+ transport in both normal
and CF HNEC, and that EPI-hNE4 could potently block
this effect.
Figure 1 Representative traces of short-circuit current measurements showing the effect of hNE in control and CF HNEC. HNEC from
control (WT) or CF patients (ΔF508) grown on Snapwell filters and mounted in Ussing chamber were exposed apically to hNE (final
concentration: 10 and 33 μg/ml) for 30 minutes before amiloride (final concentration: 10 μM) was added.
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clearance is partly dependent on the volume of airway
surface liquid (ASL) on airway surfaces. The ASL is
comprised of a periciliary liquid layer, which lubricates
the cell surface, and a mucus layer, which traps airborne
particules and pathogens. Cystic fibrosis airways exhibit
Na
+ hyperabsorption and Cl
- hyposecretion, which leads
to ASL volume depletion, mucus stasis and mucus plug-
ging, which promote persistent bacterial infections [1].
Recent findings yielded novel insights into the role of
ENaC hyperactivity in the in vivo pathogenesis of CF.
Mall et al have demonstrated in a mouse model, that
overexpression of the b-subunit of ENaC was sufficient
to increase airway Na
+ absorption in vivo [6]. In this
animal model, elevated airway Na
+ absorption caused
airway surface liquid depletion, reduced mucus clear-
ance, and deficient mucus clearance produced sponta-
neous lung disease sharing key features with CF [6,26].
Because ENaC hyperactivity in the airways is thought to
play a key role in the pathogenesis of CF, decreasing
ENaC-mediated Na
+ transport represents a therapeutic
target to control ASL volume in CF airways.
It has been recently shown that ENaC channels
expressed at the cell surface can be activated in vitro
and in vivo by various trypsin-like serine proteases
Figure 2 Effect of hNE and trypsin on transepithelial Na
+ transport across control and CF HNEC. HNEC from control (panel A) or CF
(ΔF508) patients (panel B) grown on Snapwell filters and mounted in Ussing chamber were exposed apically to hNE, trypsin or vehicle. ΔIsc was
calculated as the difference between the value of short-circuit current (Isc) at the end of exposure to drug or vehicle and the baseline Isc at the
moment of drug or vehicle addition. Results are expressed in μA/cm
2 and represent means ± SE of five to seven filters for each condition:
vehicle, hNE (10 μg/ml), hNE (33 μg/ml), and trypsin (100 μg/ml).
Table 2 Effect of the hNE inhibitor EPI-hNE4 on ΔIsc in HNEC from control and CF patients
Control HNEC CF HNEC
Vehicle EPI-hNE4 (100 μg/ml) Vehicle EPI-hNE4 (100 μg/ml)
ΔIsc (μA/cm
2) 0.5 ± 2.60 -0.9 ± 2.91 0.2 ± 2.15 -0.3 ± 2.52
Human nasal epithelial cells (HNEC) from control (non CF) and CF patients grown for 14 to 21 days on semi-permeable transwell filters were mounted in Ussing
chamber and treated apically with either the hNE inhibitor EPI-hNE4 (final concentration 100 μg/ml) or vehicle. ΔIsc represents the difference between final Isc
value at the end of experiment and basal Isc value before apical addition of vehicle or EPI-hNE4 in control and CF HNEC. Results are expressed as means ± SE
(n = 4-5 individual filters for each condition).
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Proteases, which are co-expressed with ENaC in airway
and alveolar epithelial cells [15,20-22,24] but also in
other epithelial cells transporting Na
+ [12,14] have the
ability to stimulate ENaC activity by increasing the
channel opening probability, most likely through proteo-
lytic cleavage of g-ENaC subunit [9,16]. The effect of
CAPs in lung epithelial cells is mimicked in vitro by
trypsin, a serine protease which is normally not present
in lung tissue [15,21,27]. Human neutrophil elastase is
another serine protease present in CF airways at high
concentrations due to the unrelenting infection and
inflammation of the airways. Interestingly, Caldwell et al
have recently reported that ENaC activity and transe-
pithelial Na
+ transport could be increased by apical
treatment with hNE in a human airway epithelial cell
line [18]. The mechanism whereby hNE could activate
ENaC function has been further analyzed in the xenopus
laevis oocyte expression system. Harris et al have
demonstrated that hNE could cleave the g subunit of
ENaC at cell surface [28]. It can be therefore hypothe-
sized that ENaC activation by hNE in vivo could in
some way contribute to ENaC hyperactivity encountered
in CF airways. However, as the models previously used
to study the effect of hNE, either airway epithelial cell
lines or xenopus laevis oocytes, may be far from the
in vivo conditions, we found it useful to study the effect
of hNE on Na
+ transport across both normal and CF
human primary epithelial cells.
Our experiments showed that apical addition of
increasing concentrations of hNE did not significantly
modify transepithelial Na
+ transport as assessed by Isc
measurements in normal or CF HNEC. These results
are in sharp contrast with those obtained by Caldwell
et al in a human airway cell line [18]. Yet, they are not
really surprising as previous studies have demonstrated
that apical treatment with the exogenous serine protease
trypsin had no effect on sodium current in human nasal
epithelial cells and in rat alveolar epithelial cells [15,21],
suggesting that in these primary cells, ENaC was fully
activated by epithelium-derived serine proteases such as
C A P s .I ti si m p o r t a n tt on o t et h a tt h ec e l ll i n eu s e db y
Caldwell et al obviously did not show any endogenous
CAP activity inasmuch as aprotinin (a non specific CAP
inhibitor) incubation did not decrease Na
+ transport
[18]. Therefore, we hypothesized that the lack of effect
of hNE on Isc in our experiments was due to the fact
that ENaC channels, once inserted in the plasma mem-
brane, were already maximally activated by CAPs so
that hNE could not further increase ENaC activity. Con-
sistent with this hypothesis, we demonstrated that hNE
was able to activate ENaC and transepithelial Na
+ trans-
port in both normal and CF HNEC, but only when
endogenous serine proteases such as CAPs were inhib-
ited by aprotinin. Of note, we observed that inhibition
of Na
+ transport by aprotinin was significantly larger in
CF HNEC than in control HNEC. This finding, in line
with what was previously reported by Myerburg et al
Figure 3 Representative traces of short-circuit current measurements showing the effect of hNE in control and CF HNEC incubated
with aprotinin. HNEC from control (WT) and CF (ΔF508) patients grown on Snapwell filters were mounted in Ussing chamber and incubated
apically with aprotinin (final concentration: 50 μg/ml) for 90 min before hNE (final concentration: 33 μg/ml) was added.
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teases, most likely CAPs, is increased in CF airways. We
also noticed that, although hNE-stimulated Isc after
aprotinin tended to be larger in CF than in control
HNEC, hNE treatment failed to restore Na
+ transport at
baseline value in CF cells, unlike in control cells. This
suggests that in CF HNEC, hNE cannot fully substitute
for aprotinin-sensitive epithelial serine proteases.
Another objective of the study was to test the effect of
EPI-hNE4, a specific and potent inhibitor of hNE
derived from the second Kunitz-type domain of inter-a-
inhibitor protein [22,28], on ENaC and transepithelial
Na
+ across primary HNEC. Our data show that under
baseline conditions, EPI-hNE4 by itself did not modify
Isc in normal or CF HNEC. This indicates that EPI-
hNE4 does not inhibit CAP activity in these cells, which
is not really surprising considering the fact that this
compound is highly selective for hNE. However, EPI-
hNE4 completely blocked the increase in Isc induced by
hNE in cells first incubated with aprotinin.
Taken together, our results indicate that hNE is a
potent activator of ENaC in primary nasal epithelial
cells, but the physiological importance of this effect is
questionable, inasmuch as ENaC seems to be constitu-
tively maximally activated by epithelium-derived serine
proteases such as CAPs, at least under physiological
conditions. As far as we could see, EPI-hNE4 potently
inhibited hNE, but failed to inhibit endogenous epithe-
lium-derived CAPs, at least at the concentration used in
this study. Yet, the present study does not rule out the
Figure 4 Effect of hNE on transepithelial Na
+ transport across control and CF HNEC treated with aprotinin. HNEC from control (panel A)
and CF (ΔF508) (panel B) patients grown on Snapwell filters and mounted in Ussing chamber were exposed apically to vehicle, aprotinin (50
μg/ml), or aprotinin (for 90 min) followed by hNE (33 μg/ml). ΔIsc was calculated as the difference between the value of short-circuit current (Isc)
at the end of exposure to drug or vehicle and the baseline Isc at the moment of drug or vehicle addition. Results are expressed in μA/cm
2 and
represent means ± SE of four to ten filters for each condition. **, ***: significantly different from vehicle (P < 0.01 and P < 0.001, respectively); §,
§§: significantly different from aprotinin alone (P < 0.05 and P < 0.01, respectively).
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airway inflammation encountered during CF, activation
of ENaC by excess hNE released by neutrophils could
be important. Interestingly, it has been reported that
prostasin (CAP1) expression was markedly decreased in
renal epithelial cells (M1 cell line) treated with TGFb-1,
a prototypic inflammatory cytokine [30]. Therefore, one
can speculate that the expression and activity of endo-
genous CAPs might as well be reduced during airway
inflammation, and that the stimulatory effect of hNE on
ENaC could be unmasked. On this condition, the use of
EPI-hNE4 could be of interest to reduce ENaC hyperac-
tivity in CF airways. In order to elucidate the role of
hNE on transepithelial Na
+ transport under inflamma-
tory conditions, we intend to expose HNEC to prototy-
pic inflammatory cytokines such as TGFb-1 or IL1-b,
which are known to decrease ENaC activity in these
cells [25,30,31], and to study the effect of hNE.
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